Editorial

Insights & Research

Deep-dives, opinion, and science-led commentary on immuno-oncology, biomarkers, and precision medicine — from the ImmunoMark editorial team and guest contributors.

Featured

April 2026 · 11 min read

Boston Biotech & Life Sciences Events 2026: Complete Guide

Boston Biotech & Life Sciences Events 2026: Your Complete Guide Boston has long been one of the world’s most important addresses for biotechnology and life sciences. If you…

Anwesha

Read Article →

Latest Articles

All

Why precision medicine is changing cancer treatment in 2026

Why Precision Medicine Is Changing Cancer Treatment in 2026 Precision medicine and the Statue of Liberty may have more in…

Anwesha May 2026

All

IVD Companion Diagnostic Co-Development: Structuring Pharma-Diagnostics Partnerships

IVD Companion Diagnostic Co-Development: How to Structure a Pharma-Diagnostics Partnership That Works If you work at the intersection of oncology…

Anwesha May 2026

All

ImmunoMark Summit Boston 2026: Everything You Need to Know

ImmunoMark Summit Boston 2026: Everything You Need to Know If you work at the intersection of immuno-oncology and biomarker science,…

Anwesha May 2026

All

Multiplex Immunoassay Platform Comparison Guide 2026

Multiplex Immunoassay Platforms: 2026 Comparison and Selection Guide You are standing at the platform selection crossroads again. MSD promises femtogram…

Anwesha May 2026

All

Sponsoring ImmunoMark Summit Boston: An ROI Guide for Diagnostics and Pharma Companies

Sponsoring ImmunoMark Summit Boston: An ROI Guide for Diagnostics and Pharma Companies You have been here before. A promising conference,…

Anwesha May 2026

All

CAR-T Cell Therapy Biomarkers: Can We Finally Predict Who Will Respond?

CAR-T Cell Therapy Biomarkers: Can We Finally Predict Who Will Respond? You have a patient. Relapsed, refractory, eligible for CAR-T.…

Anwesha May 2026

Join us for our Upcoming Editions

400+ senior leaders. Two streams. One agenda: advancing precision oncology.